Access cutting-edge untreated advanced or metastatic gastric, gastroesophageal junction , or esophageal adenocarcinoma treatment through this clinical trial at a research site in Denver. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Denver location
Preparing your pre-screening questions…
Access untreated advanced or metastatic gastric, gastroesophageal junction , or esophageal adenocarcinoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related untreated advanced or metastatic gastric, gastroesophageal junction , or esophageal adenocarcinoma treatment provided free
Check if you qualify for this untreated advanced or metastatic gastric, gastroesophageal junction , or esophageal adenocarcinoma clinical trial in Denver, CO
No-Cost Study Care
Local to Denver
Convenient for CO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This study is being done to learn more about a new medicine called PF-08634404 and how well it works when given with chemotherapy to people with gastroesophageal cancer that is locally advanced (spread to nearby tissues) or has spread to other parts of the body. To join the study, participants must meet the following conditions: Be 18 years or older. Have locally advanced or metastatic gastric, gastroesophageal junction or esophageal adenocarcinoma Be treatment naïve for advanced or metastatic disease Be in good physical condition and have healthy organs based on medical tests. The study has two parts: * In the first part, researchers will check how safe the study medicine in combination with chemotherapy is and how well people respond to it. * In the second part, they will compare study medicine plus chemotherapy to another approved treatment (nivolumab plus chemotherapy) to see which works better. The treatment will be given in repeated time periods called cycles.
Sponsor: Pfizer
Yes, this clinical trial (NCT07392892) has an active research site in Denver, CO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for untreated advanced or metastatic gastric, gastroesophageal junction , or esophageal adenocarcinoma treatment options in Denver, CO, this clinical trial (NCT07392892) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Denver research site is actively enrolling participants for this clinical trial. You'll receive care from experienced untreated advanced or metastatic gastric, gastroesophageal junction , or esophageal adenocarcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all untreated advanced or metastatic gastric, gastroesophageal junction , or esophageal adenocarcinoma clinical trials near you to find additional studies recruiting in your area.
See all esophageal cancer clinical trials recruiting in Denver — not just this study.
Browse Esophageal Cancer Trials in Denver →